WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Price
Valuation Score
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
ICLR
ICON PLC
$301.61$137.85118.79%36.34x20.70x3.03x2.64x1.14x$1.17B4.70%$9.43B114.23$28.19B17.39
FONR
FONAR CORP
$16.01N/AN/A8.47xN/A1.01x0.66xN/A$12.25M11.88%$163.89M25.46$90.04M3.50
STRR
STAR EQUITY HOLDINGS INC
$0.92$22.88-95.98%0.57xN/A0.31x0.22x0.02x$3.23M22.52%$65.30M4.18-$772.50k-0.03
RVTY
REVVITY INC
$102.60$68.8549.02%18.45x14.85x4.61x1.61x0.94x$9.90M0.08%$7.87B63.73$15.79B12.68
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$232.69$189.5822.74%25.10x16.04x2.89x3.32x0.59x$365.37M3.07%$3.60B70.22$14.74B14.36
NEOG
NEOGEN CORP
$12.25$3.43257.35%612.50x19.44x2.86x0.84x1.29x-$12.98M-0.49%$3.15B14.53$3.38B17.92
TMO
THERMO FISHER SCIENTIFIC INC
$574.99$367.7156.37%37.05x21.23x5.18x4.69x0.71x$7.01B3.16%$46.74B121.08$246.09B22.25
IDXX
IDEXX LABORATORIES INC
$468.04$84.40454.53%44.87x42.20x10.44x24.64x6.03x$796.79M2.05%$1.57B18.88$39.31B31.65
A
AGILENT TECHNOLOGIES INC
$138.69$70.9695.45%32.86x23.08x6.03x6.57x1.02x$1.65B4.06%$6.19B21.12$41.45B24.53
ENZ
ENZO BIOCHEM INC
$1.04$23.75-95.62%1.55xN/A4.09x0.75x0.02x-$45.92M-87.40%$70.78M1.40$139.76k0.00
QGEN
QIAGEN NV
$42.81$21.5099.08%29.16x17.16x4.94x2.66x1.11x$367.58M3.84%$3.60B16.08$10.57B15.55
DGX
QUEST DIAGNOSTICS INC
$137.55$80.4071.08%18.27x15.60x1.64x2.38x1.23x$947.00M6.20%$6.43B57.95$20.16B11.84
SHC
SOTERA HEALTH CO
$11.27$30.76-63.36%62.61x9.16x3.02x7.18x0.13x-$362.71M-11.46%$443.73M1.58$5.21B12.81
MEDP
MEDPACE HOLDINGS INC
$397.86$56.17608.33%39.12x54.50x6.25x18.36x398.25x$473.34M3.86%$671.54M21.77$12.06B29.70
DHR
DANAHER CORP
$246.89$151.7462.70%41.42x21.16x8.12x3.42x0.73x$5.57B3.05%$53.44B72.16$194.00B25.74
CSTL
CASTLE BIOSCIENCES INC
$22.02N/AN/A-10.29x-10.15x2.69x1.54xN/A-$19.23M-3.26%$391.27M14.60$520.92M-11.57
WAT
WATERS CORP
$315.92$161.4195.72%29.06x21.67x6.31x16.26x1.09x$442.18M2.37%$1.15B19.47$20.75B20.73
LH
LABORATORY CORP OF AMERICA HOLDINGS
$201.32$230.88-12.80%39.47x10.08x1.38x2.13x0.35x$683.20M4.03%$7.96B94.43$22.84B14.71
MTD
METTLER TOLEDO INTERNATIONAL INC
$1,249.75$534.83133.67%34.62x25.84x7.21x-179.03x1.30x$861.39M3.15%-$149.94M-6.86$28.85B24.61
PRE
PRENETICS GLOBAL LTD
$4.91N/AN/A-0.88x-8.18x2.76x0.29xN/A-$13.43M-22.42%$206.36M16.91$16.59M-0.30
SERA
SERA PROGNOSTICS INC
$10.43N/AN/A-8.99xN/A1,043.00x4.82xN/A-$27.01M-8.30%$70.16M2.25$335.60M-9.65
IQV
IQVIA HOLDINGS INC
$232.94$118.6096.40%31.52x19.19x2.86x6.92x1.04x$1.50B3.50%$6.11B33.25$54.80B16.83
TWST
TWIST BIOSCIENCE CORP
$31.96N/AN/A-8.85x-8.55x7.00x3.13xN/A-$128.84M-7.01%$590.04M10.26$1.67B-9.85
PRPO
PRECIPIO INC
$5.62N/AN/A-1.25xN/A0.48x0.56xN/A-$3.69M-50.52%$14.43M11.12$7.65M-1.77
NTRA
NATERA INC
$94.15N/AN/A-24.91x-29.89x10.00x14.86xN/A-$286.15M-2.64%$765.33M6.66$11.16B-29.11
PSNL
PERSONALIS INC
$1.55N/AN/A-0.69x-0.71x1.02x0.60xN/A-$67.17M-89.94%$129.44M2.69$59.62M-0.63
DRIO
DARIOHEALTH CORP
$1.46N/AN/A-0.76x-0.75x2.04x0.74xN/A-$30.96M-74.73%$58.14M2.05$35.73M-0.66
FLGT
FULGENT GENETICS INC
$20.70N/AN/A-3.68x-26.88x2.13x0.54xN/A$5.57M0.90%$1.14B38.15$520.25M-3.88
OLK
OLINK HOLDING AB (PUBL)
$22.68N/AN/A-90.72x453.60x16.63x5.61xN/A-$48.97M-1.74%$502.70M4.04$2.73B-135.98
ACRS
ACLARIS THERAPEUTICS INC
$1.26N/AN/A-0.99x-0.79x2.81x0.57xN/A-$79.63M-90.56%$157.18M2.25$49.91M-0.57
NEO
NEOGENOMICS INC
$13.96N/AN/A-21.15x-27.92x2.88x1.93xN/A-$39.59M-2.25%$923.41M7.32$2.06B1,552.89
DMTK
DERMTECH INC
$0.62N/AN/A-0.20x-0.19x1.32x0.37xN/A-$77.88M-386.71%$57.18M1.75$35.55M-0.37
STIM
NEURONETICS INC
$3.56N/AN/A-3.39x-4.13x1.43x3.09xN/A-$34.41M-33.78%$34.19M1.19$108.58M-4.77
EXAS
EXACT SCIENCES CORP
$60.01N/AN/A-53.11x-26.55x4.32x3.46xN/A$31.93M0.29%$3.15B17.46$12.84B246.03
OCX
ONCOCYTE CORP
$2.55N/AN/A-0.68x0.91x13.01x1.03xN/A-$23.25M-119.18%$20.47M2.68$12.83M-0.49
BGLC
BIONEXUS GENE LAB CORP
$0.61N/AN/A-3.36xN/A1.00x1.12xN/A-$1.45M-14.82%$9.66M0.61$8.37M-3.37
RDNT
RADNET INC
$50.45$13.88263.39%1,009.00x95.19x1.98x5.48x1.30x$44.35M1.38%$630.70M9.92$4.60B17.34
BNR
BURNING ROCK BIOTECH LTD
$0.75N/AN/A-0.85x-0.98x1.03x0.72xN/A-$36.49M-47.59%$106.28M1.04-$6.76M0.09
LAB
STANDARD BIOTOOLS INC
$2.54N/AN/A-2.70xN/A1.89x-4.98xN/A-$46.12M-22.95%-$148.05M-1.87$783.41M-11.93
APDN
APPLIED DNA SCIENCES INC
$4.03N/AN/A-0.37x0.06x0.31x0.81xN/A-$7.67M-278.41%$4.23M6.19$429.48k-0.07
XGN
EXAGEN INC
$1.36N/AN/A-1.01x-1.01x0.46x1.03xN/A-$15.27M-63.46%$22.69M1.28$10.18M-0.56
GH
GUARDANT HEALTH INC
$18.26N/AN/A-4.27x-3.62x3.63x14.01xN/A-$345.46M-16.89%$158.68M1.42$2.41B-5.57
XWEL
XWELL INC
$1.71N/AN/A-0.26xN/A0.24x0.55xN/A-$17.98M-251.81%$13.00M3.11$9.06M-0.37
BDSX
BIODESIX INC
$1.25N/AN/A-1.95x-2.72x2.09x26.46xN/A-$45.93M-44.72%$4.58M0.06$155.58M-4.19
CDNA
CAREDX INC
$9.18N/AN/A-2.59x-17.32x1.76x1.82xN/A-$26.73M-5.41%$261.33M4.86$420.82M-2.31
CHEK
CHECK-CAP LTD
$2.30N/AN/A-0.76x-0.96xN/A0.49xN/A-$17.74M-131.83%$27.40M4.68$9.97M-0.52
ME
23ANDME HOLDING CO
$0.50N/AN/A-0.45xN/A0.97x0.64xN/A-$194.26M-80.80%$377.19M0.78$76.46M-0.16
NDRA
ENDRA LIFE SCIENCES INC
$0.29N/AN/A-0.18xN/AN/A0.56xN/A-$9.57M-524.04%$5.66M0.89$727.73k-0.07
ULS
UL SOLUTIONS INC
$34.85N/AN/A26.81xN/A2.60xN/AN/A$252.00M3.62%$654.00M3.27N/AN/A
PRPH
PROPHASE LABS INC
$5.19N/AN/A-5.30x6.65x2.01x1.90xN/A-$14.46M-16.18%$49.38M2.87$112.89M-7.61
NOTV
INOTIV INC
$3.92N/AN/A-3.02xN/A0.17x0.40xN/A$6.48M6.40%$254.16M9.87$507.62M8.52
OPK
OPKO HEALTH INC
$1.27N/AN/A-5.08x-10.58x1.11x0.64xN/A-$41.76M-4.41%$1.39B1.85$1.10B-16.73
AWH
ASPIRA WOMEN's HEALTH INC
$3.22N/AN/A-1.78x-0.52x3.25x-16.81xN/A-$15.92M-53.54%-$2.37M-0.26$39.75M-2.41
VNRX
VOLITIONRX LTD
$0.87N/AN/A-1.73xN/A78.73x-9.11xN/A-$19.15M-31.06%-$7.80M-0.11$56.20M-1.67
GENE
GENETIC TECHNOLOGIES LTD
$2.36N/AN/A-0.79xN/A0.08x0.17xN/A-$5.00M-1,100.76%$3.15M16.35-$1.64MN/A
ISPC
ISPECIMEN INC
$0.27N/AN/A-0.22xN/A0.24x0.25xN/A-$10.55M-433.83%$9.74M1.08$297.11k-0.03
MYGN
MYRIAD GENETICS INC
$19.47N/AN/A-6.12xN/A2.14x2.23xN/A-$184.20M-11.43%$783.20M9.46$1.77B-9.51
BIAF
BIOAFFINITY TECHNOLOGIES INC
$2.45N/AN/A-2.69xN/A8.45x5.81xN/A-$6.06M-28.29%$4.86M0.56$26.97M-3.53
ILMN
ILLUMINA INC
$124.68N/AN/A-16.99x21.46x4.37x3.45xN/A$283.00M1.44%$5.75B36.36$20.94B-34.44
MDXH
MDXHEALTH SA
$2.67N/AN/A-0.19x-2.10x0.10x-7.49xN/A-$24.92M-342.10%-$973.00k-0.36$100.49M-4.70
PMD
PSYCHEMEDICS CORP
$2.62N/AN/A-3.64xN/A0.68x2.26xN/A-$1.64M-10.88%$6.67M1.16$15.38M-20.03
TRIB
TRINITY BIOTECH PLC
$1.75N/AN/A-0.55xN/A0.24x-0.56xN/A-$14.57M-108.63%-$23.95M-3.12$77.15M-6.86
MYNZ
MAINZ BIOMED NV
$0.75N/AN/A-0.46xN/A13.64x4.89xN/A-$23.84M-195.73%$3.25M0.20$15.19M-0.62
MMA
ALTA GLOBAL GROUP LTD
$3.16N/AN/A-0.60xN/A21.07xN/AN/A-$5.92M-18.32%-$69.50M-6.80N/AN/A
CNTG
CENTOGENE NV
$0.44N/AN/A-0.28xN/A0.22x-0.73xN/A-$28.26M-232.73%-$16.55M-0.60$61.87M-1.39
TTOO
T2 BIOSYSTEMS INC
$3.00N/AN/A-0.16xN/A1.09x-0.59xN/A-$48.33M-617.23%-$28.04M-10.74$49.79M-1.17

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in May 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the top diagnostic & research stock with a Zen Score of 50, which is 22 points higher than the diagnostic & research industry average of 28. It passed 16 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 54.32% over the past year, overperforming other diagnostic & research stocks by 57 percentage points.

Icon has an average 1 year price target of $344.38, an upside of 14.18% from Icon's current stock price of $301.61.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Icon, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the second best diagnostic & research stock with a Zen Score of 47, which is 19 points higher than the diagnostic & research industry average of 28. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 1.14% over the past year, overperforming other diagnostic & research stocks by 3 percentage points.

3. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the third best diagnostic & research stock with a Zen Score of 46, which is 18 points higher than the diagnostic & research industry average of 28. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 31.85% over the past year, overperforming other diagnostic & research stocks by 34 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 2.99%, which is 2 percentage points higher than the diagnostic & research industry average of 1.35%.

Qiagen Nv's dividend payout ratio of 87.2% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.09%, which is 1 percentage points higher than the diagnostic & research industry average of 1.35%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.43%, which is the same as the diagnostic & research industry average of 1.35%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 56.5% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks up?

Diagnostic & research stocks were up 0.7% in the last day, and down -0.56% over the last week.

We couldn't find a catalyst for why diagnostic & research stocks are up.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 31.85% in the past year. It has overperformed other stocks in the diagnostic & research industry by 34 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -57.89% in the past year. It has underperformed other stocks in the diagnostic & research industry by -56 percentage points.

3. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Icon has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Icon's stock has gained 54.32% in the past year. It has overperformed other stocks in the diagnostic & research industry by 57 percentage points.

Are diagnostic & research stocks a good buy now?

52.08% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 11.35% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.5x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.